Under construction – not a live service
Sign in

NCT06181227TerminatedPhase 2

A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema

A Phase 2 Study to Evaluate the Safety and Treatment Effect of Intravitreal AVD-104 in Participants With Diabetic Macular Edema

Source: ClinicalTrials.gov · Last updated 14 Jul 2025

Brief summary (registry, in English)

A Phase 2 study to determine the safety and preliminary efficacy of intravitreal injections of AVD-104, a novel glyco-mimetic nanoparticle, in reducing macular edema associated with diabetic retinopathy.

Status (registry)
Terminated
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
21 (actual)
First submitted
28 Nov 2023
Start date
30 Nov 2023
Primary completion date
5 Apr 2024
Lead sponsor
Aviceda Therapeutics, Inc.
NCT number
NCT06181227

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Any IVT anti-vascular endothelial growth factor (VEGF) treatment within 3 months before randomization

Other illness

  • Any history of pan-retinal photocoagulation (PRP) treatment
  • History of macular laser photocoagulation

Other

  • Any use of Iluvien® (Alimera Sciences, Inc., Alpharetta, GA) in the last 3 years; or Ozurdex® (Abbvie, Chicago, IL) or Xipere (Bausch \& Lomb, Vaughan, Ontario, Canada) in the last 6 months
  • Any signs of high-risk proliferative diabetic retinopathy (PDR)

Who the study is looking for

  • Diagnosis of diabetes mellitus (type 1 or 2), as defined by the World Health Organization and/or American Diabetes Association
  • Decreased visual acuity (VA) due to DME, with Best corrected visual acuity (BCVA) letter score of 75-20 letters on ETDRS-like charts (20/32-20/320 Snellen equivalent)
  • DME represented by macular thickening on Spectral domain optical coherence tomography (SD-OCT) involving the center of the macula: Central subfield thickness (CST) ≥325 μm

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Texas Retina AssociatesDallasUnited StatesUnknown status
Erie Retina ResearchErieUnited StatesUnknown status
West Texas Retina ConsultantsWichita FallsUnited StatesUnknown status

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.